These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10287683)

  • 1. LyphoMed, FDA reach agreement.
    Wagner M
    Mod Healthc; 1988 May; 18(22):6. PubMed ID: 10287683
    [No Abstract]   [Full Text] [Related]  

  • 2. LyphoMed hopes to put troubles behind it.
    Wagner M
    Mod Healthc; 1989 Jan; 19(2):57. PubMed ID: 10291291
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA initiative will enhance drug good manufacturing practices.
    FDA Consum; 2002; 36(6):4. PubMed ID: 12523283
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory controls--an FDA investigator's viewpoint.
    Avallone HL
    J Parenter Sci Technol; 1986; 40(5):178-82. PubMed ID: 3794896
    [No Abstract]   [Full Text] [Related]  

  • 5. ISO 9000. Policy implications for FDA. Taking the pulse of increasing global use of the ISO series of uniform quality standards by FDA regulated industries.
    Schwemer WL; Lynch MA
    J Parenter Sci Technol; 1993; 47(3):101-18. PubMed ID: 8360802
    [No Abstract]   [Full Text] [Related]  

  • 6. Generics still a favorite Rx for savings.
    Wagner M
    Mod Healthc; 1990 May; 20(21):26-8, 30, 32-3. PubMed ID: 10104890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EC/FDA joint inspections.
    Nasto B
    Nat Biotechnol; 2008 Aug; 26(8):847. PubMed ID: 18688225
    [No Abstract]   [Full Text] [Related]  

  • 8. PDA response. FDA advance notice of proposed rulemaking on electronic identification/signatures. Parenteral Drug Association.
    J Parenter Sci Technol; 1993; 47(1):4-8. PubMed ID: 8445499
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA action spurs change in groups' drug programs.
    Perry PA
    Hosp Mater Manage; 1989 Nov; 14(11):1, 13-4. PubMed ID: 10295911
    [No Abstract]   [Full Text] [Related]  

  • 10. Watching Washington. Interview by David Cassak.
    Wilbur B
    Surg Bus; 1980 Aug; 43(8):42-5, 48-9. PubMed ID: 10248427
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA asks LyphoMed to recall intravenous solution.
    Wagner M
    Mod Healthc; 1988 Jul; 18(31):5. PubMed ID: 10288204
    [No Abstract]   [Full Text] [Related]  

  • 12. There may be a 483 in your future.
    Edwards CM
    J Parenter Drug Assoc; 1979; 33(4):203-13. PubMed ID: 260938
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA and notices of observations (FDA forms 483).
    Loftus BT
    J Parenter Drug Assoc; 1978; 32(5):209-15. PubMed ID: 251197
    [No Abstract]   [Full Text] [Related]  

  • 14. Strengthening drug manufacturing practices.
    Hecht A
    FDA Consum; 1976; 10(6):12-4. PubMed ID: 829227
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of Abbott's consent decree on clinical laboratories.
    Assarian GS
    MLO Med Lab Obs; 2000 Sep; 32(9):56-8. PubMed ID: 11184639
    [No Abstract]   [Full Text] [Related]  

  • 16. The challenges of process analytical technologies in chemical development.
    Grosso JA; Landau RN; Confalone PN
    Curr Opin Drug Discov Devel; 2005 Nov; 8(6):682-3. PubMed ID: 16312144
    [No Abstract]   [Full Text] [Related]  

  • 17. Validation--mission completed?
    Sharp J
    J Parenter Sci Technol; 1993; 47(1):2-3. PubMed ID: 8445494
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating out-of-specification laboratory results.
    Vogel PF
    J Parenter Sci Technol; 1993; 47(6):276-80. PubMed ID: 8120730
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceutical product integrity: can the FDA assure quality?
    Bernstein I
    Manag Care; 2004 Mar; 13(3 Suppl):30-3. PubMed ID: 15074168
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA inspections in Canada.
    Oliver EA
    J Parenter Sci Technol; 1991; 45(3):142-6. PubMed ID: 1886042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.